Table 1.
Clinicopathological characteristics of the patients with cervical squamous cell carcinoma in the RT-sensitive group (CC-RS) and RT-resistant (CC-RR) group
| Variables | No. patients (N = 20) |
Radiosensitivity | |
|---|---|---|---|
| CC-RS (N = 10) |
CC-RR (N = 10) |
||
| Age (years) | |||
| < 45 | 13 | 6 (46.2) | 7 (53.8) |
| ≥ 45 | 7 | 4 (57.1) | 3 (42.9) |
| FIGO stage | |||
| IIIa | 8 | 3 (37.5) | 5 (62.5) |
| IIIb | 12 | 7 (58.3) | 5 (41.7) |
| SCC-Ag value | |||
| 1.5–10 | 15 | 7 (46.7) | 8 (53.3) |
| > 10 | 5 | 3 (60.0) | 2 (40.0) |
| Tumor size(cm) | |||
| ≤ 4 | 14 | 6 (42.9) | 8 (57.1) |
| > 4 | 6 | 4 (66.7) | 2 (33.3) |
| Deep stromal invasion | |||
| No | 5 | 3 (60.0) | 2 (40.0) |
| Yes | 15 | 7 (46.7) | 8 (53.3) |
| Pelvic lymph node metastasis | |||
| No | 12 | 7 (58.3) | 5 (41.7) |
| Yes | 8 | 3 (37.5) | 5 (62.5) |
CC-RS cervical cancer patients in RT-sensitive group, CC-RR cervical cancer patients in RT-resistant group, FIGO Federation International of Gynecology and Obstetrics, SCC squamous cell carcinoma